Related Experiment Video
Updated: May 31, 2025

Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures
Published on: December 14, 2019
Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects
Yi-Jing Hsiao1,2, Min-Shu Hsieh3, Gee-Chen Chang4,5,6,7,8
1Department of Clinical and Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.
Abstract:
The spatial role of M1 and M2 tumor-associated macrophages (M1/M2 TAMs) in precision medicine remains unclear. EGFR and TP53 are among the most frequently mutated genes in lung adenocarcinoma. We characterized the mutation status and density of M1/M2 TAMs within tumor islets and stroma in 117 lung adenocarcinomas using next-generation sequencing and immunohistochemistry, respectively. Stromal M1 TAMs were positively correlated with disease progression and smoking history. In contrast, islet M1/M2 TAMs were predominantly found in tumors with wild-type TP53 (wtp53) but not associated with EGFR status. The presence of wtp53 was associated with the spatial distribution of M1/M2 TAMs in tumor islets and stroma. Additionally, dominance of islet M1 TAMs and M1-signature were significantly associated with improved survival in patients with wtp53 lung adenocarcinoma, unlike in those with mutant TP53. Conditioned medium from M1 macrophages (M1 CM) induced apoptosis in wtp53 cells through increased p53 accumulation. We found that interferons in M1 CM activate JAK1/TYK2 via IFNARs, leading to enhanced STAT1 expression and Y701 phosphorylation. This activation facilitates p53-STAT1 interactions, reduces the interaction between p53 and MDM2, and subsequently decreases p53 ubiquitination. M1 CM inhibited tumorigenesis, and silencing p53 reduced the anti-tumor efficacy of polyinosinic:polycytidylic acid (poly I:C) in vivo. Furthermore, higher M1-signature was significantly associated with better responses and survival following anti-PD1 treatment in wtp53 melanomas. IFNs/STAT1/p53 signaling was critical for the anti-tumor activity of M1 macrophages. These findings suggest that p53 modulates the spatial balance of M1/M2 TAMs, and the tumoricidal effects of M1 TAMs depend on p53 status. Thus, p53 companion diagnostics could facilitate the development of M1-oriented therapies, which may be particularly beneficial for wtp53 patients when combined with immunotherapy.
Insights
Tumor-associated macrophages (TAMs) play a spatial role in lung cancer. Wild-type TP53 status influences M1/M2 TAM distribution and predicts better survival, especially with M1 macrophage dominance and immunotherapy.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- The spatial distribution and function of M1 and M2 tumor-associated macrophages (M1/M2 TAMs) in lung adenocarcinoma are not fully understood.
- EGFR and TP53 are common mutations in lung adenocarcinoma, potentially influencing the tumor microenvironment.
Purpose of the Study:
- To investigate the spatial characteristics and density of M1/M2 TAMs in relation to EGFR and TP53 mutation status in lung adenocarcinoma.
- To elucidate the functional role of M1 TAMs in wild-type TP53 (wtp53) lung adenocarcinoma and their impact on patient survival and response to therapy.
Main Methods:
- Next-generation sequencing and immunohistochemistry were used to analyze mutation status and M1/M2 TAM density in 117 lung adenocarcinomas.
- In vitro studies examined the effect of M1 macrophage conditioned medium (M1 CM) on wtp53 lung cancer cells, including apoptosis induction and signaling pathway activation (JAK/STAT/p53).
- In vivo experiments assessed the anti-tumor efficacy of M1 CM and polyinosinic:polycytidylic acid (poly I:C) in a p53-dependent manner.
Main Results:
- Stromal M1 TAMs correlated with disease progression and smoking history.
- Islet M1/M2 TAMs were prevalent in wtp53 tumors, with their distribution linked to wtp53 status.
- Dominance of islet M1 TAMs and M1 signature were associated with improved survival in wtp53 lung adenocarcinoma patients.
- M1 CM induced apoptosis in wtp53 cells via interferon-mediated JAK/STAT/p53 signaling, inhibiting tumorigenesis.
- Higher M1 signature predicted better response to anti-PD1 therapy in wtp53 melanomas.
Conclusions:
- TP53 status critically modulates the spatial distribution and anti-tumor activity of M1/M2 TAMs in lung adenocarcinoma.
- The anti-tumor effects of M1 TAMs are dependent on p53 status, highlighting a mechanism involving interferon-JAK/STAT-p53 signaling.
- p53 companion diagnostics could guide M1-oriented therapies, particularly for wtp53 patients, potentially enhancing immunotherapy efficacy.
More Related Videos
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Related Concept Videos
Abnormal Proliferation
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...